内容概况：喷墨打印机是非接触式打印机，通过将墨滴推过纸张和塑料基材上的喷嘴来重建数字图像。 喷墨技术包括离子墨水，该墨水由磁性板引导以喷射到纸张上。这些打印机用于各种行业，例如广告， 纺织，包装，教育和制药。受益于消费市场家庭用户的增加，2017-2022年我国喷墨打印机出货量逐年 增加。2023-2024年，受到经济环境波动，用户预算收紧和消费降级等因素的影响，喷墨打印机市场呈 现持续两年负增长。2024年中国喷墨打印机出货量为729.2万台，同比下降8.7%。其中，一季度受2023 年同期高基数影响出现下滑，二季度到四季度都呈现同比增加的趋势。尤其是2024年下半年，开学季的 需求高于预期，直播平台实时的互动性、直观的展示以及精准影响，持续提升了打印机在学生群体中的 重要性。此外，随着价格持续下探，用户获取信息渠道更加广泛，喷墨打印机低成本优势受到更多用户 推崇。自由办公人群增加，倾向于购买喷墨打印机兼顾家庭和工作需求；中小企业从激光转向喷墨的趋 势愈发显著。未来，随着经济环境改善、消费需求回升以及喷墨打印技术的持续创新，喷墨打印机出货 量或将恢复增长态势。 | 喷墨打印机的分类 | | | --- | ...

Financial Performance - The company reported revenue of approximately RMB 149,737,000 for 2024, a decrease of about 26% compared to 2023, with a net loss attributable to shareholders of approximately RMB 59,834,000[7]. - For the year ended December 31, 2024, the group's revenue was approximately RMB 149,737,000, a decrease of about 26% compared to the previous year[17]. - The loss attributable to shareholders was approximately RMB 59,834,000, a reduction in loss of RMB 19,635,000 compared to 2023[17]. - The basic loss per share for 2024 was approximately RMB 0.098, compared to RMB 0.130 for the year ended December 31, 2023[17]. - As of December 31, 2024, total assets were approximately RMB 206,138,000, down from RMB 254,190,000 in 2023[20]. - The current ratio decreased to approximately 0.73 from 0.91 in the previous year, primarily due to an increase in borrowings of about RMB 26,763,000[20]. Revenue Breakdown - Printer business revenue was approximately RMB 130,139,000, accounting for about 87% of total revenue, also down by approximately 26% year-on-year due to the promotion of electronic invoices in mainland China[11]. - Other product revenue was approximately RMB 19,598,000, representing about 13% of total revenue, which also decreased by approximately 26% due to reduced sales of medical products following the end of the pandemic[12]. Gross Profit and Margins - The gross profit margin increased to 12% due to a reduction in inventory provisions despite the overall operating loss[7]. - The gross profit margin increased from 11% in 2023 to 12% in 2024 due to a decrease in inventory provisions[18]. Future Plans and Product Development - The company plans to launch a cost-effective multifunctional inkjet printer and laser printer products in the second quarter of 2025[8]. - A smart cloud self-service delivery cabinet for logistics applications is expected to be launched in 2025[8]. - The company aims to develop a full range of portable oxygen machines with capacities from 3L to 15L, targeting the high-altitude oxygen subsidy policy set to be introduced by the government by the end of 2024[8]. - The company plans to launch a high-altitude oxygen machine in the first half of 2025, targeting the new national subsidy policy for high-altitude oxygen[16]. - New product launches include medical devices, inkjet printing, cloud printing, and self-service terminals, which are expected to aid in market transformation and capture[47]. Employee and Organizational Information - The group employed 572 staff as of December 31, 2024, down from 670 in the previous year[28]. - Employee satisfaction has been consistently above the target score of 87, with a score of 88.4 in 2024[52]. - The company has established a safety committee and implemented an occupational health and safety management system based on ISO45001 standards[197]. - Employee training facilities accommodate over 100 people, providing both online and offline training opportunities[200]. Corporate Governance - The company has complied with the corporate governance code, except for the chairman's absence at the annual general meeting due to other commitments[85]. - The board consists of two executive directors, one non-executive director, and three independent non-executive directors, ensuring a balanced skill set and experience necessary for the company's operations[101]. - The independent non-executive directors represent more than one-third of the board, allowing for independent opinions and guidance[101]. - The company has established mechanisms to ensure independent opinions are provided to the board, enhancing governance practices[101]. Environmental, Social, and Governance (ESG) Initiatives - The company has set specific ESG goals, including a 3% reduction in water usage compared to the previous year and achieving 100% certification for energy-efficient products[162]. - The company achieved a significant reduction in wastewater discharge, totaling 41,437 tons in 2024, down by 3,952 tons from 2023[181]. - The company reported that all emissions from its production processes met national standards, with particulate matter emissions at less than 20 mg/m³ in 2024, significantly lower than the reference limit of 120 mg/m³[179]. - The company has established an Environmental Management Team to oversee daily operations related to safety and environmental management[159]. Risk Management and Compliance - The company has a structured risk management framework to identify and assess significant risks affecting its operations[131]. - The company emphasizes compliance with relevant laws and regulations in both mainland China and Hong Kong, ensuring adherence to significant legal requirements[59]. - The company has established a comprehensive internal control department to investigate allegations and report findings to the board in real-time if criminal evidence is disclosed[151]. Shareholder Communication and Relations - The company emphasizes effective communication with shareholders to enhance investor relations and understanding of business performance and strategy[137]. - The company is committed to maintaining ongoing communication with shareholders, particularly through annual and special general meetings[137]. - The company ensures that all communications with shareholders are bilingual to facilitate understanding[140].

Financial Performance - For the fiscal year ending December 31, 2024, the total revenue was RMB 3,149,737 thousand, a significant increase from RMB 203,484 thousand in 2023[3] - The net loss for the year was RMB (60,262) thousand, an improvement from a net loss of RMB (79,793) thousand in 2023, reflecting a 24% reduction in losses[5] - Total revenue for the year ended December 31, 2024, was RMB 149,737,000, a decrease of 26.4% from RMB 203,484,000 in 2023[24] - The group reported a net loss of RMB 60,262,000 for the year ended December 31, 2024, compared to a net loss of RMB 79,793,000 in 2023, indicating an improvement of 24.5%[24] - The basic and diluted loss per share improved to RMB (0.098) from RMB (0.130) in the previous year[4] Revenue and Segments - Revenue from the printing machine segment decreased by approximately 26% due to the nationwide implementation of digital electronic invoices[16] - Revenue from external customers for the printer segment was RMB 130,139,000, down from RMB 176,848,000 in 2023, representing a decline of 26.4%[24][25] - For the fiscal year ending December 31, 2024, the company's revenue from the printer business was approximately RMB 130,139,000, accounting for about 87% of total revenue, a decrease of approximately 26% compared to 2023[42] - For the year ending December 31, 2024, the group's other products revenue was approximately RMB 19,598,000, accounting for about 13% of total revenue, a decrease of approximately 26% compared to 2023 due to reduced sales of medical products following the pandemic's decline[43] Expenses and Cost Management - The cost of goods sold decreased to RMB (131,363) thousand from RMB (180,961) thousand, resulting in a gross profit of RMB 18,374 thousand compared to RMB 22,523 thousand in the previous year[3] - Research and development expenses were reduced to RMB (15,064) thousand from RMB (20,615) thousand, indicating a 27% decrease year-over-year[3] - The company reported a significant decrease in administrative expenses to RMB (32,985) thousand from RMB (39,158) thousand, a reduction of about 16%[3] - The group’s sales and marketing expenses were RMB 27,123,000 in 2024, compared to RMB 30,985,000 in 2023, a reduction of 12.5%[24][29] - The total cost of goods sold and expenses recognized in 2024 was RMB 206,535,000, down from RMB 271,719,000 in 2023, a decrease of 24.0%[29] Assets and Liabilities - Total assets decreased to RMB 206,138 thousand from RMB 254,190 thousand, representing a decline of approximately 19%[6] - The company's total liabilities increased to RMB 196,807 thousand from RMB 177,415 thousand, marking an increase of about 11%[8] - The group's current liabilities exceeded current assets by approximately RMB 46,089,000 as of December 31, 2024[14] - The total accounts receivable as of December 31, 2024, was RMB 40,930,000, an increase from RMB 31,613,000 in 2023[38] - The total accounts payable as of December 31, 2024, was RMB 45,272,000, slightly up from RMB 44,746,000 in 2023[39] Financing and Cash Flow - The group has secured standby financing of RMB 35,000,000, including an unused amount of RMB 20,000,000, to ensure financial resources when needed[17] - The total bank borrowings amounted to approximately RMB 136,431,000, with RMB 112,431,000 due within 12 months[14] - Cash and cash equivalents decreased to RMB 24,434 thousand from RMB 37,291 thousand, a decline of approximately 34%[6] - The group’s borrowings increased to approximately RMB 140,797,000 from RMB 111,034,000 year-over-year[54] Corporate Governance and Compliance - The company has adhered to all corporate governance codes as per the Hong Kong Stock Exchange listing rules, except for the attendance of the chairman at the annual general meeting due to other business commitments[68] - The Audit Committee has reviewed the group's financial statements for the year ending December 31, 2024, ensuring completeness, accuracy, and fairness[67] - The company has fully complied with the standard code of conduct regarding director securities transactions for the year ending December 31, 2024[71] Future Outlook and Strategy - The group anticipates that domestic demand for printing machines will stabilize and plans to continue developing enhanced functionalities and expanding sales channels[17] - The company expects market demand to recover in 2025 due to government policies aimed at stimulating consumption and supporting manufacturing, alongside the gradual market introduction of medical products[44] - The company plans to launch a cloud printing machine for small and medium-sized wholesalers in 2024, facilitating remote printing and integrated management of store inventory[45] - The company plans to launch a high-altitude version of a specialized oxygen machine in the first half of 2025, in response to national policies on oxygen supplementation[49] Employee and Operational Metrics - The group employed 572 staff as of December 31, 2024, down from 670 employees in the previous year[62] - The company’s capital expenditures for the year ending December 31, 2024, were approximately RMB 1,797,000, primarily for the purchase of production equipment and product molds[52] Taxation - The corporate income tax rate for Jiangyu Information is 15% for the fiscal year ending December 31, 2024, down from 25% in 2023, due to its qualification as a high-tech enterprise[32] - The company’s income tax rate applicable in Hong Kong remains at 16.5% for both fiscal years 2024 and 2023[31]

| --- | --- | |-------|-------| | | | | | | ● ● 目錄 2 公司資料 3 管理層討論與分析 9 中期財務資料審閱報告 11 簡明綜合中期資產負債表 13 簡明綜合中期收益表 14 簡明綜合中期全面收益表 15 簡明綜合中期權益變動表 16 簡明綜合中期現金流量表 17 簡明綜合中期財務資料附註 35 其他資料 公司資料 | --- | --- | |---------------------------------------------------------------------------------|---------------------------------------------------------------------------------------| | | | | 董事 | 提名委員會 | | 執行董事 | 簡麗娟女士 （主席） | | 歐栢賢先生 （主席） 歐國倫先生 （行政總裁） | 孫寶源先生 楊國強先生 | | 非執行董事 | 核數師 | | 歐國良先生 | 羅兵咸永道會計師事務所 執業會計師 | | 獨立非執行董事 | ...

Financial Performance - The company's revenue for the six months ended June 30, 2024, was RMB 84,237,000, a decrease of 28.6% compared to RMB 117,988,000 for the same period in 2023[1]. - The gross loss for the period was RMB 3,973,000, compared to a gross profit of RMB 22,281,000 in the previous year, indicating a significant decline in profitability[1]. - Operating loss increased to RMB 38,530,000 from RMB 29,821,000 year-on-year, reflecting ongoing challenges in the business[2]. - The net loss attributable to shareholders for the period was RMB 43,406,000, compared to RMB 34,232,000 in the same period last year, representing a 27% increase in losses[2]. - The company reported a basic and diluted loss per share of RMB 0.071, compared to RMB 0.056 in the same period last year, reflecting worsening financial performance[2]. - For the six months ending June 30, 2024, the group recorded a loss of approximately RMB 43,495,000 and a net cash outflow from operating activities of approximately RMB 18,686,000[9]. - The group reported a loss of RMB 43,495 thousand for the six months ended June 30, 2024, compared to a loss of RMB 34,431 thousand for the same period in 2023[15]. - The comprehensive gross loss for the group was RMB 3,973,000, with a gross margin of -5%, primarily due to provisions for inventory impairment of approximately RMB 8,580,000 and long-term asset impairment of approximately RMB 17,692,000[39]. Assets and Liabilities - Total assets decreased to RMB 206,709,000 as of June 30, 2024, down from RMB 254,190,000 at the end of 2023, indicating a reduction in the company's asset base[4]. - The company's total liabilities were RMB 176,198,000, slightly down from RMB 177,415,000 at the end of 2023, showing a stable liability position[6]. - Cash and cash equivalents fell to RMB 27,539,000 from RMB 37,291,000, highlighting liquidity challenges[4]. - As of June 30, 2024, the group's current liabilities exceeded its current assets by approximately RMB 33,707,000[9]. - The company's current ratio was approximately 0.78 as of June 30, 2024, down from 0.91 as of December 31, 2023, due to a decrease in current assets of approximately RMB 17,107,000[41]. Revenue Segmentation - Revenue from the printer segment accounted for about 44% of total revenue for the six months ended June 30, 2024, compared to 19% for the same period in 2023[17]. - For the six months ended June 30, 2024, the company's revenue from printer business was approximately RMB 71,741,000, accounting for about 85% of total revenue, and decreased by approximately 31% compared to the same period in 2023[30]. - Revenue from other products for the same period was approximately RMB 12,496,000, representing about 15% of total revenue, and decreased by approximately 9% year-on-year, primarily due to the delayed market launch of medical products[31]. - The revenue from the printing machine segment decreased by 31% due to a decline in demand for needle printers, influenced by the nationwide implementation of digital electronic invoices[9]. Research and Development - Research and development expenses decreased to RMB 6,768,000 from RMB 11,644,000, suggesting a potential reduction in innovation efforts[1]. - The group incurred research and development expenses of RMB 6,768 thousand for the six months ended June 30, 2024, compared to RMB 5,452 thousand for the same period in 2023[14]. - The company has developed a series of SaaS applications based on cloud printing, including "E Invoice" and "Reimbursement Without Worry," aimed at small and medium-sized enterprises[35]. Future Outlook and Strategies - The group anticipates that the domestic market demand for needle printers has stabilized and continues to develop enhanced functionalities for these printers[10]. - The group is optimistic about the sales potential and growth in the emerging consumer printing equipment market and medical device market, which is expected to provide additional cash inflow in 2024 and 2025[10]. - The company plans to strengthen the application of needle printers in manufacturing, e-commerce, logistics, and internal management of trade enterprises in the second half of 2024[32]. - The company aims to expand the market for medical device products in the second half of 2024[32]. - The company plans to launch the "PC Cloud Printer" in 2023, enhancing market competitiveness through cloud technology[33]. - The company is conducting clinical trials for a pulse oximeter expected to launch by the end of 2024, which will integrate oxygen generation and blood oxygen monitoring[37]. Cost Management - The group has implemented strict cost and expenditure control measures in the second quarter of 2024 to reduce operating cash outflows[11]. - The company has implemented cost-saving measures that are projected to reduce expenses by E million annually[52]. Corporate Governance and Compliance - The company has maintained compliance with corporate governance codes, with a noted absence of the chairman at the annual general meeting due to other business commitments[49]. - The interim financial information for the six months ended June 30, 2024, has been reviewed by the audit committee and independent auditors[51]. Employee and Dividend Information - The total number of employees as of June 30, 2024, is 621, a decrease from 670 employees as of December 31, 2023[46]. - The company did not recommend the payment of an interim dividend for the six months ended June 30, 2024[25].

Financial Performance - The company recorded revenue of approximately RMB 203,484,000 in 2023, a decrease of about 27% compared to 2022, with a net loss attributable to shareholders of approximately RMB 79,469,000[6]. - Revenue from the printer business was approximately RMB 176,848,000, accounting for about 87% of total revenue, which represents a decrease of approximately 30% year-on-year[11]. - Revenue from other products was approximately RMB 26,636,000, accounting for about 13% of total revenue, showing an increase of approximately 3% due to higher sales of medical products[12]. - The gross profit margin declined to 11% in 2023, reflecting ongoing operational losses[6]. - The net loss attributable to shareholders was approximately RMB 79,469,000, an increase in loss of RMB 39,442,000 compared to 2022[21]. - The gross profit margin declined to 11% due to inventory impairment provisions and long-term asset impairment provisions[22]. - As of December 31, 2023, total assets were approximately RMB 254,190,000, down from RMB 356,597,000 in 2022[24]. - The company had cash and cash equivalents of approximately RMB 37,291,000, a decrease from RMB 68,974,000 in the previous year[26]. - The company’s leverage ratio increased to 42.8% as of December 31, 2023, compared to 33.3% in the previous year[26]. Product Development and Innovation - The company has developed portable medical oxygen machines (5L and 7L), with the 7L model already registered for sale in the domestic market[6]. - The company is expanding its product offerings, including new inkjet printers tailored for the medical sector and cloud printing solutions[14]. - The company has launched several SAAS applications, including "E开单" for remote printing and "报销无忧" for online reimbursement processes[17]. - The company is focusing on integrating hardware and software products to provide digital invoice services for various industries[14]. - The company aims to enhance its market competitiveness through the introduction of cloud printing technology and new product lines[14]. - The company completed the development of equivalent 5L and 7L portable medical oxygen concentrators, with the 7L model receiving certification in December 2023[20]. - The company plans to develop a 10L portable medical oxygen concentrator and a low-noise 5L remote-controlled oxygen concentrator for severe patients in 2024[20]. - New product certifications achieved in 2023 include a small molecular sieve oxygen generator, which has commenced mass production[66]. Market Outlook and Strategy - Future business outlook remains positive, with expectations of government policies to stimulate consumption and support manufacturing, potentially restoring market demand[13]. - The company is focusing on developing cloud printing technology and launching various products suitable for electronic invoicing to meet market demands[52]. - The company plans to position itself as a cloud application service provider, expanding printing equipment applications and offering integrated online and offline retail solutions[53]. - The company is actively developing new products in sectors such as medical devices, inkjet printing, and self-service terminals to enhance market presence[55]. - The company aims to enhance its product core technology and expand sales channels to maintain reasonable profit levels amid intense competition[57]. Corporate Governance and Compliance - The company is committed to maintaining high corporate governance standards and has complied with the relevant rules of the Hong Kong Stock Exchange for the year ending December 31, 2023[102]. - The board of directors includes experienced professionals with diverse backgrounds in finance, technology, and management, contributing to the company's strategic direction[109]. - The company has adopted the corporate governance code and complied with all relevant provisions for the year ended December 31, 2023[119]. - The company has mechanisms in place to ensure independent opinions and contributions from independent non-executive directors, who constitute more than one-third of the board[129]. - The company aims to enhance investor confidence and accountability through strict corporate governance practices[102]. Employee and Stakeholder Engagement - Employee satisfaction score reached 92.9 in 2023, maintaining above 90 for several years[61]. - The company implemented a salary adjustment in January 2023, alongside an annual bonus scheme based on operational performance[62]. - The company contributes 14% of employee salaries to the retirement benefit fund for its Chinese subsidiaries[88]. - In Hong Kong, the company contributes 5% of each employee's monthly salary to the Mandatory Provident Fund, with a cap of HKD 1,500 per employee[88]. - The company aims to enhance shareholder communication and participation through its corporate governance structure[158]. - The company is committed to maintaining effective communication with shareholders to enhance long-term value[162]. Environmental and Social Responsibility - The company has established a comprehensive ESG management focus, including improving environmental performance and promoting a diverse workplace culture[198]. - The company achieved a 100% rating for energy efficiency labels on its printer products[191]. - Water consumption was reduced by 3% compared to the previous year[191]. - The total amount of non-hazardous waste emissions decreased by 5% year-on-year[191]. - The company has set a goal to ensure 100% of hazardous waste is handled by qualified recyclers[191]. - The group is committed to sustainable development and corporate social responsibility, integrating these principles into its operational planning[186]. Risk Management - The company has identified several key risks, including policy risks related to tax regulations affecting sales of impact printers[52]. - The company is addressing supply chain risks by signing quality assurance agreements with suppliers and managing procurement and production plans[56]. - The group has established a comprehensive internal control and risk management system to safeguard assets and ensure the reliability of financial data[155]. - The board has confirmed that the risk management and internal control systems are adequate and effective, complying with corporate governance codes[156]. Shareholder Information - The company did not recommend the payment of a final dividend for the year ending December 31, 2023, consistent with the previous year[36]. - As of December 31, 2023, the company's distributable reserves amounted to approximately RMB 226,428,000[46]. - The total number of shares available for issuance under the 2015 Plan is 60,481,950 shares, equivalent to 10% of the issued shares at the time of adoption[73]. - As of December 31, 2023, there are 1,600,000 unexercised options remaining from the 2020 grant, representing 0.26% of the issued share capital[75]. - The exercise price for the options granted in 2020 is set at HKD 0.130 per share[77]. - The 2015 Plan will remain effective until May 17, 2025, unless terminated by a resolution at a shareholders' meeting[73].

Financial Performance - Total revenue for the year 2023 was RMB 203,484,000, a decrease of 27.5% compared to RMB 279,191,000 in 2022[3] - Gross profit for 2023 was RMB 22,523,000, with a gross margin of approximately 11.1%[3] - The net loss for the year 2023 was RMB 79,793,000, compared to a net loss of RMB 40,009,000 in 2022, representing a 99.4% increase in losses[4] - Basic and diluted loss per share for 2023 was RMB 0.130, compared to RMB 0.065 in 2022, indicating a 100% increase in loss per share[4] - Total revenue for the year ended December 31, 2023, was approximately RMB 203.484 million, a decrease of 27% from RMB 279.191 million in 2022[30] - The group reported a net loss of RMB 79.793 million for the year ended December 31, 2023, compared to a net loss of RMB 40.009 million in 2022[30] - The company's pre-tax loss for 2023 was RMB 75,650,000, compared to a loss of RMB 35,075,000 in 2022, indicating a significant increase in losses[38] - The loss attributable to shareholders was approximately RMB 79,469,000, an increase in loss of RMB 39,442,000 compared to 2022[63] Assets and Liabilities - Total assets decreased to RMB 254,190,000 in 2023 from RMB 356,597,000 in 2022, a decline of 28.8%[8] - Total liabilities decreased to RMB 177,415,000 in 2023 from RMB 200,522,000 in 2022, a reduction of 11.5%[10] - The group’s current liabilities exceeded its current assets by approximately RMB 13,243,000 as of December 31, 2023[17] - Total bank borrowings amounted to approximately RMB 108,749,000, with RMB 87,224,000 due within the next 12 months[17] - Cash and cash equivalents decreased to RMB 37,291,000 in 2023 from RMB 68,974,000 in 2022, a decline of 46.0%[8] - The group reported a net cash outflow from operating activities of about RMB 19,599,000 for the year ended December 31, 2023[17] Revenue Segments - Revenue from external customers in the printer segment was RMB 176.848 million, accounting for about 87% of total revenue, down from RMB 253.273 million in 2022[32] - The revenue from the printing machine segment decreased by 30% due to a significant reduction in demand for needle printers following the nationwide implementation of digital electronic invoices[18] - Other products generated revenue of approximately RMB 26,636,000, representing about 13% of total revenue, an increase of approximately 3% compared to 2022, primarily driven by increased sales of medical products[51] - The printer business generated revenue of approximately RMB 176,848,000, accounting for about 87% of total revenue, a decrease of approximately 30% compared to 2022 due to the nationwide implementation of digital electronic invoices and insufficient market demand[50] Expenses - Research and development expenses increased to RMB 27,978,000 in 2023 from RMB 20,615,000 in 2022, an increase of 35.6%[3] - Administrative expenses increased slightly to RMB 39.158 million in 2023 from RMB 38.600 million in 2022[30] - The group reported a total of RMB 271.719 million in expenses for the year, a decrease from RMB 313.561 million in the previous year[36] - The group incurred financing costs of RMB 5.715 million, down from RMB 6.242 million in 2022[37] - The total income tax expense for 2023 was RMB 4,143,000, a decrease from RMB 4,934,000 in 2022, showing a reduction of approximately 16%[38] Market Outlook and Strategy - The group plans to expand its product offerings in emerging consumer printing equipment and medical device markets, expecting additional cash inflow in 2024[20] - The company anticipates a continued decline in printer demand due to the promotion of electronic invoices, but expects recovery in market demand in 2024 supported by government policies to stimulate consumption and the introduction of new medical products[52] - The company has developed new inkjet printers targeting the medical industry and launched a cloud printing machine that enhances market competitiveness[54] - The company plans to develop a 10L portable medical oxygen machine and a low-noise remote-controlled 5L oxygen machine in 2024[61] - The company is focusing on integrating software and hardware products to provide digital electronic invoice services for industries like catering and retail[54] Corporate Governance - The board believes that the group will have sufficient financial resources to meet its operational funding needs for at least the next 12 months[20] - The company did not declare any dividends for the year ending December 31, 2023, consistent with the previous year[45] - The board of directors did not recommend a final dividend for the year ended December 31, 2023, consistent with the previous year[80] - The company has established a share option scheme to reward and motivate employees[78] - The audit committee reviewed the group's performance for the year ended December 31, 2023[87] - The company has complied with all corporate governance codes except for the attendance of the chairman at the annual general meeting due to other business commitments[88] Employee and Operational Changes - As of December 31, 2023, the group employed 670 staff, a decrease from 768 staff in 2022[78] - Strict cost and expense control measures have been implemented to reduce operating cash outflow[20] - The accounts payable to third parties decreased from RMB 32,593,000 in 2022 to RMB 27,978,000 in 2023, indicating improved cash flow management[48] - The accounts payable aged less than 30 days decreased significantly from RMB 18,278,000 in 2022 to RMB 8,235,000 in 2023, reflecting better payment practices[48] Reporting and Compliance - The annual performance announcement and annual report will be published on the Hong Kong Stock Exchange website and the company's website[93] - The annual report for the year ending December 31, 2023, will be sent to shareholders and made available for viewing on the aforementioned websites[93] - The report will include all information required by the listing rules[93] - The company is committed to ensuring the accuracy of the information provided in the report[93] - The report will detail the company's financial performance and future outlook[93] - The company will focus on market expansion and new strategies in the upcoming year[93] - The company aims to enhance its product and technology development initiatives[93]

Financial Performance - Total revenue for the year 2023 was RMB 203,484,000, a decrease of 27.2% compared to RMB 279,191,000 in 2022[3] - Gross profit for 2023 was RMB 22,523,000, compared to RMB 65,099,000 in 2022, reflecting a significant decline[3] - Operating loss for 2023 was RMB 66,318,000, an improvement from the operating loss of RMB 28,589,000 in 2022[3] - Net loss attributable to shareholders for 2023 was RMB 79,469,000, compared to RMB 40,027,000 in 2022, indicating a worsening financial performance[4] - Basic and diluted loss per share for 2023 was RMB 0.130, compared to RMB 0.065 in 2022[4] - The group reported a net loss of RMB 79.793 million for the year ended December 31, 2023, compared to a net loss of RMB 40.009 million in 2022[30] - The company's pre-tax loss for 2023 was RMB 75,650,000, compared to a loss of RMB 35,075,000 in 2022, indicating a significant increase in losses[38] - The basic and diluted loss per share for 2023 was RMB 0.130, compared to RMB 0.065 in 2022, reflecting a 100% increase in loss per share[44] - The loss attributable to shareholders was approximately RMB 79,469,000, an increase in loss of RMB 39,442,000 compared to 2022[63] Assets and Liabilities - Total assets decreased to RMB 254,190,000 in 2023 from RMB 356,597,000 in 2022, a decline of 28.8%[8] - Total liabilities decreased to RMB 177,415,000 in 2023 from RMB 200,522,000 in 2022, a reduction of 11.5%[10] - Cash and cash equivalents decreased to RMB 37,291,000 in 2023 from RMB 68,974,000 in 2022, a decline of 46.0%[8] - Inventory decreased to RMB 70,098,000 in 2023 from RMB 101,399,000 in 2022, a reduction of 30.8%[8] - The group's current liabilities exceeded its current assets by approximately RMB 13,243,000 as of December 31, 2023[17] - The total bank borrowings amounted to approximately RMB 108,749,000, with RMB 87,224,000 due within the next 12 months[17] Research and Development - The company reported a significant increase in research and development expenses, rising to RMB 27,978,000 in 2023 from RMB 20,615,000 in 2022[3] - Research and development expenses totaled RMB 20.615 million, compared to RMB 27.978 million in 2022, indicating a reduction in investment in this area[30] - The company has developed new inkjet printers targeting the medical industry, including dual-color inkjet printers and specialized printing solutions for government and enterprise sectors[53] - The company launched a cloud printing machine in 2023, enhancing the competitiveness of its traditional printers by upgrading them to cloud printing capabilities[54] - The company has introduced various self-service terminal products, utilizing unique core technologies in smart governance and healthcare sectors[55] - The company has successfully obtained medical registration for a portable oxygen concentrator, which is designed for patients with respiratory issues, featuring advanced technology for oxygen delivery[59] Market and Sales - The revenue from the printing machine segment decreased by 30% due to a significant reduction in demand for needle printers following the nationwide implementation of digital electronic invoices[18] - Revenue from external customers in the printer segment was RMB 176.848 million, accounting for about 87% of total revenue, down from RMB 253.273 million in 2022[32] - The printer business generated revenue of approximately RMB 176,848,000, accounting for about 87% of total revenue, a decrease of approximately 30% compared to 2022 due to the nationwide implementation of digital invoices and insufficient market demand[50] - Other products generated revenue of approximately RMB 26,636,000, accounting for about 13% of total revenue, an increase of approximately 3% compared to 2022, primarily driven by increased sales of medical products[51] - The company anticipates that the demand for invoice printers will continue to decline in 2024 due to the promotion of electronic invoices, but expects market demand to recover with government policies to stimulate consumption and support manufacturing[52] - The group is optimistic about the sales potential and growth in the emerging markets, which is expected to contribute stable cash inflow in 2024[21] Cost Management - Strict cost and expense control measures were implemented in the last quarter of 2023 to reduce operating cash outflow[20] - Administrative expenses for the year were RMB 39.158 million, slightly increased from RMB 38.600 million in the previous year[30] - Financing costs decreased to RMB 5.715 million in 2023 from RMB 6.242 million in 2022, reflecting a reduction in interest expenses[37] Corporate Governance and Compliance - The group did not recommend a final dividend for the year ended December 31, 2023, consistent with the previous year[80] - The group has implemented a share option plan to reward and motivate employees[78] - The audit committee has reviewed the group's performance for the year ended December 31, 2023[87] - The company has complied with the corporate governance code, except for the chairman's absence at the annual general meeting due to other business commitments[88] - There were no significant events affecting the group after December 31, 2023, up to the announcement date[79] Employment and Workforce - As of December 31, 2023, the group employed 670 staff, a decrease from 768 staff in 2022[78]

目 錄 公司資料 2 管理層討論與分析 3 簡明綜合中期資產負債表 8 簡明綜合中期收益表 10 育明綜合中期全面收益表 11 簡明綜合中期權益變動表 12 簡明綜合中期現金流量表 13 簡明綜合中期財務資料附註 14 其他資料 30 IoImark Jolimark Holdings Limited 映美控股有限公司 (於開曼群島註冊成立之有限公司) 股份代號：2028 2023 中期報告 公司資料 董事 執行董事 歐栢賢先生 （主席） 歐國倫先生 （行政總裁） 非執行董事 歐國良先生 獨立非執行董事 簡麗娟女士 鍾曉林博士 楊國強先生 註冊辦事處 Windward 3 Regatta Office Park PO Box 1350 Grand Cayman KY1-1108 Cayman Islands 香港主要營業地點 香港 北角 渣華道191 號 嘉華國際中心 21 樓07 室 公司秘書 賴世和先生 授權代表 歐國倫先生 賴世和先生 審核委員會 簡麗娟女士 （主席） 鍾曉林博士 楊國強先生 薪酬委員會 楊國強先生 （主席） 鍾曉林博士 簡麗娟女士 歐國倫先生 提名委員會 簡麗娟女士 （主席） 鍾曉林博 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告 全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 JOLIMARK HOLDINGS LIMITED 映 美 控 股 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：2028） 截 至 二 零 二 三 年 六 月 三 十 日 止 六 個 月 中 期 業 績 公 告 未經審核綜合業績 映美控股有限公司（「本公司」）董事（「董事」）會（「董事會」）謹此宣佈，本公司及其 附屬公司（「本集團」）截至二零二三年六月三十日止六個月（「本期間」）之未經審 核綜合業績，連同去年同期的比較數字如下： 簡明綜合中期收益表 截至六月三十日止六個月 二零二三年 二零二二年 未經審核 未經審核 附註 人民幣千元 人民幣千元 ...